Interestingly, PTMA, the proprotein of thymosin alpha-1 (Tα1), has been reported to show increased expression in CD8 T memory cells in severe disease and slightly reduced activation of T cells in vitro (45), and the authors indicated that lymphopenia in COVID-19 patients could be relieved by Tα1 treatment. Here, CD8A is linked to COVID-19.